Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Sofinnova Partners
Deal Size : $21.7 million
Deal Type : Financing
DISCO Pharmaceuticals Launches as Surfaceome Company with EUR 20 Million in Seed Funding
Details : The net proceeds will be used for the development of new treatment modalities such as antibody-drug conjugates (ADCs) and bi-specific antibodies, in oncology.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 16, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Sofinnova Partners
Deal Size : $21.7 million
Deal Type : Financing
Reset All
